abstract |
The use of a preparation comprising a C1 esterase inhibitor (C1-INH) for preventing or delaying hyperacute and/or acute rejection of xenotransplants in mammals is described. The xenotransplantation is preferably carried out in such a way that a therapeutically effective amount of the C1-INH preparation is administered to the recipient organism before the transplantation and, after the transplantation has taken place, the organism receives daily doses of the C1-INH preparation in an amount sufficient to prevent rejection of the transplant. |